Literature DB >> 15036612

Antipsychotics regulate cyclic AMP-dependent protein kinase and phosphorylated cyclic AMP response element-binding protein in striatal and cortical brain regions in mice.

Angela V Turalba1, Kimberly A Leite-Morris, Gary B Kaplan.   

Abstract

Adenosine 3',5'-monophosphate (cAMP) and cAMP-dependent protein kinase (PKA) signaling have been implicated in antipsychotic drug action. This study examines the effects of acute antipsychotic treatment using typical (haloperidol) and atypical (olanzapine) agents on cAMP signaling in dorsal striatum, nucleus accumbens and medial prefrontal cortex in mice. PKA catalytic subunit (PKA-c) and phosphorylated cAMP response element-binding protein (pCREB) levels were measured to evaluate antipsychotic drug effects. Nuclear PKA-c levels increased in the dorsal striatum after haloperidol and olanzapine treatment. In medial prefrontal cortex, olanzapine produced dose-dependent decreases in PKA-c and pCREB levels. The differential effects of typical versus atypical antipsychotic agents on PKA and pCREB in striatal and cortical regions illustrate the diverging actions of these agents on cAMP pathways.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15036612     DOI: 10.1016/j.neulet.2003.11.059

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  14 in total

Review 1.  Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection.

Authors:  Jeffrey A Lieberman; Frank P Bymaster; Herbert Y Meltzer; Ariel Y Deutch; Gary E Duncan; Christine E Marx; June R Aprille; Donard S Dwyer; Xin-Min Li; Sahebarao P Mahadik; Ronald S Duman; Joseph H Porter; Josephine S Modica-Napolitano; Samuel S Newton; John G Csernansky
Journal:  Pharmacol Rev       Date:  2008-09       Impact factor: 25.468

2.  Aripiprazole Increases the PKA Signalling and Expression of the GABAA Receptor and CREB1 in the Nucleus Accumbens of Rats.

Authors:  Bo Pan; Jiamei Lian; Xu-Feng Huang; Chao Deng
Journal:  J Mol Neurosci       Date:  2016-02-19       Impact factor: 3.444

3.  Mdivi-1 Protects Against Ischemic Brain Injury via Elevating Extracellular Adenosine in a cAMP/CREB-CD39-Dependent Manner.

Authors:  Mei Cui; Hongyan Ding; Fangzhe Chen; Yanxin Zhao; Qi Yang; Qiang Dong
Journal:  Mol Neurobiol       Date:  2014-11-27       Impact factor: 5.590

4.  Modulation by chronic antipsychotic administration of PKA- and GSK3β-mediated pathways and the NMDA receptor in rat ventral midbrain.

Authors:  Bo Pan; Chao Deng
Journal:  Psychopharmacology (Berl)       Date:  2019-05-03       Impact factor: 4.530

5.  Harnessing gene expression to identify the genetic basis of drug resistance.

Authors:  Bo-Juen Chen; Helen C Causton; Denesy Mancenido; Noel L Goddard; Ethan O Perlstein; Dana Pe'er
Journal:  Mol Syst Biol       Date:  2009-10-13       Impact factor: 11.429

6.  Clozapine-induced ERK1 and ERK2 signaling in prefrontal cortex is mediated by the EGF receptor.

Authors:  Avril Pereira; George Fink; Suresh Sundram
Journal:  J Mol Neurosci       Date:  2009-03-10       Impact factor: 3.444

Review 7.  Disruption of striatal-enriched protein tyrosine phosphatase (STEP) function in neuropsychiatric disorders.

Authors:  Takatoshi Karasawa; Paul J Lombroso
Journal:  Neurosci Res       Date:  2014-09-10       Impact factor: 3.304

Review 8.  Cyclic AMP in dendritic cells: A novel potential target for disease-modifying agents in asthma and other allergic disorders.

Authors:  Amy M Chinn; Paul A Insel
Journal:  Br J Pharmacol       Date:  2020-06-21       Impact factor: 8.739

9.  Proteome Analysis of PC12 Cells Reveals Alterations in Translation Regulation and Actin Signaling Induced by Clozapine.

Authors:  Urszula Jankowska; Bozena Skupien-Rabian; Bianka Swiderska; Gabriela Prus; Marta Dziedzicka-Wasylewska; Sylwia Kedracka-Krok
Journal:  Neurochem Res       Date:  2021-05-23       Impact factor: 3.996

10.  The Role of Striatal-Enriched Protein Tyrosine Phosphatase (STEP) in Cognition.

Authors:  Christopher James Fitzpatrick; Paul J Lombroso
Journal:  Front Neuroanat       Date:  2011-07-29       Impact factor: 3.856

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.